MOH Stock Recent News
MOH LATEST HEADLINES
MOH's Q2 earnings lag estimates as rising medical care costs offset gains from premiums and rate hikes.
The headline numbers for Molina (MOH) give insight into how the company performed in the quarter ended June 2025, but it may be worthwhile to compare some of its key metrics to Wall Street estimates and the year-ago actuals.
Molina Healthcare cut annual profit forecast for the second time this month as it expects higher medical care costs to weigh on the health insurer's results.
LONG BEACH, Calif--(BUSINESS WIRE)--Molina Healthcare, Inc. (NYSE: MOH) (the “Company”) today reported second quarter 2025 GAAP earnings per diluted share of $4.75 and adjusted earnings per diluted share of $5.48. Financial results are summarized below: Three months ended Six months ended June 30, June 30, 2025 2024 2025 2024 (In millions, except per-share results) Premium Revenue $10,868 $9,446 $21,496 $18,950 Total Revenue $11,427 $9,880 $22,574 $19.
Evaluate the expected performance of Molina (MOH) for the quarter ended June 2025, looking beyond the conventional Wall Street top-and-bottom-line estimates and examining some of its key metrics for better insight.
MOH's Q2 revenues are set to rise nearly 10%, but rising costs cloud its profit outlook.
A majority of publicly traded US health insurers are expected to post QoQ declines in revenue and net income in Q2, according to an S&P Global Market Intelligence analysis of sell-side analyst forecasts. Of the eight largest publicly traded US managed care insurers, all but two — UnitedHealth Group and Alignment Healthcare — are projected to report lower revenue compared with Q1 2025, while all eight are forecast to log higher revenue than Q2 2024. In Q2, all eight of the largest publicly traded US managed care insurers, except The Cigna Group, are expected to log lower net income sequentially, while all eight are forecast to report lower net income YoY.
FNF, MOH and CDZI have been added to the Zacks Rank #5 (Strong Sell) List on July 17, 2025.
Molina (MOH) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.